期刊文献+

2010-2014年我院大肠埃希菌耐药率与抗菌药使用量的相关性分析 被引量:5

Correlation between Escherichia coli resistance and antimicrobial usage between 2010 and 2014 in our hospital
下载PDF
导出
摘要 目的分析大肠埃希菌耐药率与抗菌药使用量之间的相关性。方法收集我院2010年1月∽2014年12月13种抗菌药用药频度(DDDs)及大肠埃希菌药敏试验结果,分析二者之间相关性。结果大肠埃希菌对头孢他啶、头孢噻肟耐药率与头孢噻肟用量呈正相关(r分别是0.913、0.884,P〈0.05),对阿莫西林/克拉维酸和头孢西丁耐药率与左氧氟沙星用量呈正相关(r分别是0.923、0.944,P〈0.05),对头孢他啶、头孢噻肟、氨曲南耐药率与哌拉西林/他唑巴坦用量呈负相关(r分别是-0.894、-0.880、-0.879,P〈0.05)。结论大肠埃希菌耐药率与抗菌药DDDs之间存在相关性。 Objective To analyze the correlation between Escherichia coli resistance and antimicrobial usage. MethodsDefined daily doses(DDDs) of 13 antimicrobial agents and susceptibility test results of E. coli were collected between January 2010 and December 2014 in our hospital, and their correlation was then analyzed. Results Resistance rates of E. coli to ceftazidime or cefotaxime, and amoxicillin/clavulanic acid or cefoxitin were positively correlated with cefotaxime(r=0.913 or 0.884, P〈0.05), and levofloxacin usage(r=0.923 or 0.944, P〈0.05), respectively; while resistance rates to ceftazidime, cefotaxime or aztreonam were negatively correlated with piperacillin/tazobactam(r=-0.894,-0.880, or-0.879, P〈0.05). Conclusion There is a significant correlation between E. coli resistance and antimicrobial DDDs.
出处 《广东医学院学报》 2015年第4期479-482,共4页 Journal of Guangdong Medical College
关键词 大肠埃希菌 抗菌药 耐药 Escherichia coli antimicrobial agent drug resistance
  • 相关文献

参考文献14

  • 1Biswas T, Das M, Mondal R, et al. Prevalence of ESBL producing Escherichia Coli and Klebsiella species with their co-resistance pattern to antimicrobials[J]. Mymensingh Med J, 2013, 22(2): 377-384.
  • 2肖永红,王进,朱燕,齐惠敏,李湘燕,赵彩云,侯芳,郑波,高磊,郝凤兰,薛峰.Mohnarin 2008年度全国细菌耐药监测[J].中华医院感染学杂志,2010,20(16):2377-2383. 被引量:569
  • 3Hsu L Y, Tan T Y, Tam V H, et al. Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals[J]. Antimicrob Agents Che- mother, 2010, 54 (3): 1173- 1178.
  • 4Mutnick A H, Rhomberg P R, Sader H S, et al. Antimicrobialusage and resistatace trend relationships from the MYSTIC Programme in North America (1999-2001)[J]. J Antimicrob Chemother, 2004, 53(2): 290-296.
  • 5裴保香,吴启北,郭秀娥.阴沟肠杆菌的耐药性与抗菌药物使用量的相关性分析[J].中华医院感染学杂志,2008,18(8):1147-1149. 被引量:24
  • 6俞云松.超广谱β-内酰胺酶研究进展[J].中华医学杂志,2006,86(9):641-644. 被引量:95
  • 7周华,李光辉,陈佰义,卓超,曹彬,杨毅,张菁,王辉,何礼贤,胡必杰,黄晓军,吕晓菊,邵宗鸿,孙自敏,刘又宁,倪语星,邱海波,施毅,王明贵,谢灿茂,周建英,周志慧,刘正印,俞云松.中国产超广谱β-内酰胺酶肠杆菌科细菌感染应对策略专家共识[J].中华医学杂志,2014,94(24):1847-1856. 被引量:259
  • 8Bantar C, Vesco E, Heft C, et al. Replacement of broad- spectrum cephalosporins by piperacillin-tazobactam: impact on sustained high rates of bacterial resistance [J]. Antimicrob Agents Chemother, 2004, 48(2):392-396.
  • 9Iosifidis E, Antachopoulos C, Tsivitanidou M, et al. Diferen- tial correlation between rates of antimicrobial drug con-sumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece[J]. Infect Control Hosp Epidemiol, 2008, 29(7): 615 - 622.
  • 10简翠,孙自镛.大肠埃希菌对氟喹诺酮类药物产生耐药性的药物蓄积减少机制[J].国外医药(抗生素分册),2006,27(2):87-90. 被引量:3

二级参考文献120

共引文献991

同被引文献59

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部